Dr. Todd Blake Heimowitz, DO

Dr. Heimowitz practices at Mount Sinai Aventura Emergency in Miami, Florida.

Dr. Heimowitz's NPI, 1972761567, was assigned on May 30, 2008. Dr. Heimowitz graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1999. Dr. Heimowitz holds Florida license OS8372.

Dr. Heimowitz's primary practice is Mount Sinai Aventura Emergency, at 2845 Aventura Blvd, Miami, FL 33180 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Heimowitz's primary practice is Mount Sinai Aventura Emergency in Miami, Florida. Dr. Heimowitz is also affiliated with Mount Sinai Medical Center. The medical group on file is Mount Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heimowitz practices. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Heimowitz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Heimowitz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Heimowitz is licensed in Florida.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Heimowitz treats.

CMS data shows 2,595 Medicare services from Dr. Heimowitz across 23 procedure codes in 2024, for 773 Medicare patients. Medicare paid $173,862 for them.

CMS counts 773 Medicare patients who saw Dr. Heimowitz in 2024. The largest group is 75 to 84, with 347 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Heimowitz's median patient age at 76, with 43% women.

In 2024, Dr. Heimowitz wrote 4,078 Medicare Part D claims for 680 patients. 84% of them were for generic drugs. CMS names the drug for 3,601 of them, across 67 drugs with 11 or more claims each, at $586,980 in total drug cost. In 2023, CMS named 4,104 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Heimowitz for performance year 2024, reported as part of a group. Dr. Heimowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Heimowitz, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Heimowitz, published from 2013 to 2022. 2013 was the busiest year, with 3. The most frequent topics are Percutaneous Coronary Intervention and Coronary Artery Disease. Dr. Heimowitz's most frequent co-authors are Orlando Santana, MD, Orlando Santana, MD and Nirat Beohar, MD.

CMS Open Payments shows 256 general payments to Dr. Heimowitz from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $1,539.

Dmand AI lists 3 awards for Dr. Heimowitz, most recently ACC Fellow in 2012.

Dr. Heimowitz graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1999. Dr. Heimowitz is a member of ACC.

Dr. Heimowitz is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.